SUS(d6)pending MHC class I peptide presentation for cancer immunoevasion

被引：0
|
作者：
Dersh, Devin [1 ]
Yewdell, Jonathan W. [2 ]
机构：
[1] Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA
[2] NIAID, Cellular Biol Sect, Lab Viral Dis, Bethesda, MD 20892 USA
来源：
CELL RESEARCH | 2024年 / 34卷 / 02期
关键词：
D O I：
10.1038/s41422-023-00882-4
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
[No abstract available]
引用
收藏
页码：97 / 98
页数：2
相关论文
共 50 条
  • [1] SUS(d6)pending MHC class I peptide presentation for cancer immunoevasion
    Devin Dersh
    Jonathan W. Yewdell
    Cell Research, 2024, 34 : 97 - 98
  • [2] Peptide presentation by MHC class I molecules
    Williams, DB
    Vassilakos, A
    Suh, WK
    TRENDS IN CELL BIOLOGY, 1996, 6 (07) : 267 - 273
  • [3] Overcoming immunoevasion in MHC class I-deficient cancers
    Danelli, Luca
    NATURE CANCER, 2024, 5 (12) : 1788 - 1788
  • [4] A few good peptides: MHC class I-based cancer immunosurveillance and immunoevasion
    Devin Dersh
    Jaroslav Hollý
    Jonathan W. Yewdell
    Nature Reviews Immunology, 2021, 21 : 116 - 128
  • [5] A few good peptides: MHC class I-based cancer immunosurveillance and immunoevasion
    Dersh, Devin
    Holly, Jaroslav
    Yewdell, Jonathan W.
    NATURE REVIEWS IMMUNOLOGY, 2021, 21 (02) : 116 - 128
  • [6] Functional screening of a retroviral peptide library for MHC class I presentation
    Tolstrup, AB
    Duch, M
    Dalum, I
    Pedersen, FS
    Mouritsen, S
    GENE, 2001, 263 (1-2) : 77 - 84
  • [7] Processing of bacterial antigens for peptide presentation on MHC class I molecules
    Wick, MJ
    Ljunggren, HG
    IMMUNOLOGICAL REVIEWS, 1999, 172 : 153 - 162
  • [8] PH dependence of MHC class I-restricted peptide presentation
    Stryhn, A
    Pedersen, LO
    Romme, T
    Olsen, AC
    Nissen, MH
    Thorpe, CJ
    Buus, S
    JOURNAL OF IMMUNOLOGY, 1996, 156 (11): : 4191 - 4197
  • [9] TAPBPR alters MHC class I peptide presentation by functioning as a peptide exchange catalyst
    Hermann, Clemens
    van Hateren, Andy
    Trautwein, Nico
    Neerincx, Andreas
    Duriez, Patrick J.
    Stevanovic, Stefan
    Trowsdale, John
    Deane, Janet E.
    Elliott, Tim
    Boyle, Louise H.
    ELIFE, 2015, 4
  • [10] Immune MAL2-practice: breast cancer immunoevasion via MHC class I degradation
    Dersh, Devin
    Yewdell, Jonathan W.
    JOURNAL OF CLINICAL INVESTIGATION, 2021, 131 (01):
12345